These opportunities are not managed nor endorsed by RCPCH. Though we do our best to ensure they are relevant and high quality, we cannot take any responsibility for their content or accuracy. If you have questions or would like to submit a joint funding application with the College, contact us on email@example.com.
Provides specialist training in cystic fibrosis medicine, and aims to train the future leaders of specialist adult CF care. Also give Fellows the opportunity to embark on clinically-based research, service evaluation or quality improvement projects, which will dovetail into their clinical training programmes.
Fund Strategic Research Centres intended to create multidisciplinary teams to address questions of strategic relevance to people with cystic fibrosis.
Funds hands-on experience of research during the academic summer vacation for promising medical and basic science undergraduates.
Designed to bring funding from external agencies into the field of cystic fibrosis research, the Venture and Innovation Awards (VIAs) support transformational and innovative research projects.
Allows exceptional established research leaders to pursue groundbreaking, high risk projects that open new directions in their respective research fields or other domains.
Supports researchers at the stage at which they are consolidating their own independent research team or programme.
Open to researchers who have already been awarded an ERC grant. This will be additional funding to establish the innovation potential of ideas arising from the ERC-funded research projects.
Aims to support up and coming research leaders who are about to establish a proper research team and to start conducting independent research in Europe. It will support the creation of excellent new research teams.
Aims to support organisations with grants in several categories including health, education, youth and community.
GOSH Charity and LifeArc are inviting translational, milestone-driven applications which aim to improve the prevention, diagnosis, prognosis, or treatment of rare disease or that focus on developing research tools that increase the efficiency of developing interventions in rare disease. The scheme is designed to support applications on the translational pathway with the expectation that researchers will continue to develop their therapy/ diagnostic after GOSH charity/LifeArc funding, either by s...